Navigation Links
Nephros Reports 2012 Fourth Quarter and Full Year Financial Results
Date:3/4/2013

ty to continue business operations;
  • even if we are able to complete the rights offering, we may not have sufficient capital to successfully implement our business plan;
  • restrictions in the secured note and related security agreement which require the prior consent of the lender may restrict our ability to operate our business, sell the company or sell our assets;
  • we may not be able to effectively market our products;
  • we may not be able to sell our water filtration products or chronic renal failure therapy products at competitive prices or profitably;
  • we may encounter problems with our suppliers and manufacturers;
  • we may encounter unanticipated internal control deficiencies or weaknesses or ineffective disclosure controls and procedures;
  • we may not obtain appropriate or necessary regulatory approvals to achieve our business plan;
  • products that appeared promising to us in research or clinical trials may not demonstrate anticipated efficacy, safety or cost savings in subsequent pre-clinical or clinical trials;
  • we may not be able to secure or enforce adequate legal protection, including patent protection, for our products; and
  • we may not be able to achieve sales growth in key geographic markets.
  • More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in our filings with the SEC, including our periodic reports filed with the SEC. We urge investors and security holders to read those documents free of charge at the SEC's web site at www.sec.gov. We do not undertake to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.

    Any information contained in this press release relating to the con
    '/>"/>

    SOURCE Nephros, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Nephros Completes Bridge Financing
    2. Nephros and Chem-Aqua Announce Distribution Agreement
    3. Nephros Reports Third Quarter 2012 Financial Results
    4. Nephros Reports Second Quarter 2012 Financial Results
    5. Nephros Reports First Quarter 2012 Financial Results
    6. Nephros Receives 510(k) Clearance for Hemodiafiltration System
    7. Nephros Appoints John C. Houghton as President and Chief Executive Officer
    8. ECRI Institute PSO Offers Key Reports on Health IT and Medication Safety for Patient Safety Awareness Week
    9. Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
    10. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
    11. IRIDEX Reports Record 2012 Fourth Quarter Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/26/2014)... architecture firm NBBJ announced today the expansion of its healthcare planning and ... will lead planning and design teams from NBBJ,s Shanghai ... clients in China , Taiwan , ... the firm,s global network of healthcare experts.   The launch ... time when the scope of the firm,s healthcare practice in ...
    (Date:8/26/2014)... , August 26, 2014 Equashield ... Transfer Devices (CSTDs) for hazardous drugs, announced today it ... top nurses from around the United States ... strategies to increase nurses, awareness of issues around occupational ... safety, and closed systems for hazardous drug transfer. ...
    (Date:8/26/2014)... , Aug. 26, 2014  Royal Philips (NYSE: PHG, ... company,s latest innovation designed to empower seniors to live ... the company,s leading U.S.-based call center, the mobile app ... recent survey by Philips and the Global ... School of Business, 96 percent of senior respondents ...
    Breaking Medicine Technology:Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 2Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 3Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 4Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 5Equashield Appoints Nurse Advisory Council 2Equashield Appoints Nurse Advisory Council 3Equashield Appoints Nurse Advisory Council 4Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 3
    ... 18, 2011 Halozyme Therapeutics, Inc. (NASDAQ: ... commercializing products targeting the extracellular matrix ... markets, today announced that the Phase 3 HannaH ... HER2-positive early breast cancer who received a new, ...
    ... /PRNewswire-iReach/ -- Dr. Anthony A. Scaduto has been named ... an interim basis effective October 14, 2011. His appointment was ... of Directors. "It is a testament to Dr. ... he was recommended by the Search Committee. He is a ...
    Cached Medicine Technology:Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 2Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 3Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 4Los Angeles Orthopaedic Hospital Announces New President and CEO 2Los Angeles Orthopaedic Hospital Announces New President and CEO 3
    (Date:8/27/2014)... PA (PRWEB) August 27, 2014 "It ... after going to the bathroom," said an inventor from ... effective way of performing this important hygienic task." He ... easy-to-use, patent-pending Fanny Wipe enables a user to wipe ... It ensures good hygiene and comfort, as well as ...
    (Date:8/27/2014)... August 27, 2014 Discover Leadership Training ... and corporate transformation through their comprehensive leadership programs. As ... has unparalleled experience in the realm of outcome-focused and ... expertise in a new webinar series titled, “A Women’s ... The first of this two part webinar is titled, ...
    (Date:8/27/2014)... CT (PRWEB) August 27, 2014 ... cyclists of all abilities to go the distance this ... Alex’s Million Mile – Run. Walk. Ride. initiative, hosted ... and increase awareness of childhood cancer. September represents ... year’s Alex’s Million Mile, Inspira Marketing Group has teamed ...
    (Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
    (Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an estimated 1 ... a number of health disorders and medical conditions. However, ... within the medical community. Many women are suffering from ... body fat around the waist area (truncal obesity), but ... by PCOS. , Awareness is the first step to ...
    Breaking Medicine News(10 mins):Health News:InventHelp Client's Device Helps a User Wipe Thoroughly After Going to the Bathroom (HLW-1300) 2Health News:Barb Moses, Vice President of Discover Leadership Training, Announces New Webinar Titled, “A Women’s Guide to Making Her Life Story a Bestseller” 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 3Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5
    ... Medical Innovations, Inc. (Amex: IMA ), a ... solutions, announced today that it will attend the upcoming ... 15, 2009 at the Westin St. Francis Hotel in ... Jon Russell, Vice President, Finance, will attend. Mr. ...
    ... Corporation (Nasdaq: BPUR ) announced today that ... stating that NASDAQ has again suspended enforcement of its ... listing, thereby extending the Company,s time in which to ... to resume on Monday, April 20, 2009. The Company ...
    ... Executive with Proven Ability to Develop Companies into ... Growth OpportunitiesFORT LAUDERDALE, Fla., Dec. 30 eDiets.com, ... provider of convenient at-home diet, fitness and healthy ... the company,s new President and CEO, effective immediately. ...
    ... didn,t halt women,s risk of developing disease , , TUESDAY, ... the supposed cancer-fighting powers of vitamins C and E, ... don,t prevent the disease in women. , And another ... new study found. , , "Simply taking antioxidant supplements ...
    ... had cancer as well as idiopathic pulmonary fibrosis, study finds ... in a gene previously found to help protect the lungs ... some inherited cases of a lethal lung disease affecting older ... the SFTPA2 gene have been found in families ...
    ... of adults and 19 percent of children taking chemotherapy drugs ... dose or experienced other mistakes involving their medications, according to ... professor of pediatrics at the University of Massachusetts Medical School, ... Journal of Clinical Oncology . , "As cancer care ...
    Cached Medicine News:Health News:Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009 2Health News:Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance 2Health News:eDiets.com(R) Appoints Kevin N. McGrath as President and CEO 2Health News:eDiets.com(R) Appoints Kevin N. McGrath as President and CEO 3Health News:Vitamins Fail to Prevent Cancer: Study 2Health News:Vitamins Fail to Prevent Cancer: Study 3Health News:Gene Mutation Tied to Inherited Fatal Lung Disease 2Health News:Errors involving medications common in outpatient cancer treatment 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: